Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.038
▾0.002 (5.00%)
Last trade: 12/12, 4:13PM
Market cap
$15.79m
Market closed
Talk to Emyria Limited directly.
Sign up to their Investor Hub for direct access to the Emyria Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Emyria Limited creates clinical evidence that accelerates the registration of new treatments for patients with unmet needs. Emyria achieves this by analysing the high quality clinical data gathered from its specialist clinical network –Emerald Clinics (www.emeraldclinics.com.au) – and turning that into Real-World Evidence (RWE), unique IP and differentiated treatment development programs.
Address
Level 1/50 Angove St, North Perth WA 6006, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.038
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.